Comparison of 454 (Roche) versus MiSeq (Illumina) deep sequencing technologies in clinical samples from the (ANRS) 139 TRIO trial

被引：0

作者：

Lee, G. Q. ^{[1
,2
]}

Lachowski, C. ^{[1
,2
]}

Martin, E. ^{[1
]}

Charpentier, C. ^{[3
]}

Rodriguez, C. ^{[3
]}

Visseaux, B. ^{[4
]}

Fagard, C. ^{[5
]}

Molin, J-M ^{[6
]}

Katlama, C. ^{[7
]}

Yazdanpanah, Y. ^{[8
]}

Descamps, D. ^{[3
]}

Poon, A. ^{[1
]}

Harrigan, P. R. ^{[1
,2
]}

机构：

[1] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada

[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[3] EA 4409 Univ Paris Diderot, Hop Bichat Claude Bernard, AP HP, Lab Virol, Paris, France

[4] Grp Hosp Paris Nord Val de Seine, Hop Bichat Claude Bernard, APHP, Lab Virol, F-75018 Paris, France

[5] INSERM U897, Bordeaux, France

[6] Univ Paris Diderot, Hop St Louis, AP HP, Serv Malad Infect, Paris, France

[7] Grp Hosp Pitie Salpetriere Charles Foix, Hop La Pitie Salpetriere, APHP, Serv Malad Infect & Trop, F-75013 Paris, France

[8] Hop Tourcoing, Serv Malad Infect & Trop, Tourcoing, France

来源：

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：A79 / A79

页数：1